Home » Topics » Briefs » Other news to note

Other news to note
RSS

GlaxoSmithKline reflects on accomplishments of first quarter 2018

May 2, 2018

AbbVie reviews milestones of first quarter 2018

April 30, 2018

Bristol-Myers Squibb updates key milestones of first quarter 2018

April 27, 2018

Amgen profiles pipeline progress of first quarter 2018

April 27, 2018

Chugai reviews highlights of first quarter 2018

April 26, 2018

Orexigen announces asset purchase agreement for sale of company

April 25, 2018

Shire willing to recommend Takeda's revised proposal to shareholders

April 25, 2018

Takeda set to begin voluntary and conditional public takeover bid for TiGenix

April 25, 2018

Third Rock Ventures launches Cedilla Therapeutics

April 25, 2018

Novartis offers overview of first quarter 2018

April 25, 2018

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...